Drug profile

The FDA adverse-event record for Canine Lyme Vaccine

162 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Canine Lyme Vaccine. See the species affected, top reactions, and outcomes below.

162
adverse-event reports
5.6%
death-coded share
Dog
most-reported species
56
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
162
Total Reports
9
Deaths Reported
5.6%
Death Rate

Active Ingredients

Canine Lyme Vaccine

Administration Routes

UnknownSubcutaneous

Species Affected

Dog 162

Most Affected Breeds

Terrier - Bull - American Pit 30
Retriever - Labrador 18
Boxer (German Boxer) 10
Siberian Husky 8
Retriever - Golden 6
Shih Tzu 5
Shepherd Dog - German 5
Maltese 5
Terrier - Jack Russell 4
Spaniel - King Charles Cavalier 4

Most Reported Reactions

Vomiting 56
Facial swelling (see also 'Skin') 44
Lethargy (see also Central nervous system depression in 'Neurological') 38
Hives (see also 'Skin') 24
Anaphylactoid reaction 22
Urticaria 19
Anaphylaxis 18
Pale mucous membrane 17
Diarrhoea 16
Panting 10
Fever 9
Emesis 7

Outcome Breakdown

Recovered/Normal
81 (50.0%)
Ongoing
67 (41.4%)
Died
7 (4.3%)
Outcome Unknown
5 (3.1%)
Euthanized
2 (1.2%)

Canine Lyme Vaccine Adverse Event Insights

162 reports name Canine Lyme Vaccine; 9 recorded a death outcome (5.6% of reported events, not a population-level mortality rate). Active ingredient: Canine Lyme Vaccine. Administration routes: Unknown, Subcutaneous.

By species: Dog (162 reports). By breed: Terrier - Bull - American Pit (30), Retriever - Labrador (18), Boxer (German Boxer) (10).

Leading clinical signs: Vomiting (56), Facial swelling (see also 'Skin') (44), Lethargy (see also Central nervous system depression in 'Neurological') (38), Hives (see also 'Skin') (24). Outcome, 162 coded reports: Recovered/Normal leads at 50.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.